IMM 2.50% 39.0¢ immutep limited

Immutep events calendar has recently grown:-1. Cancer Progress...

  1. 601 Posts.
    lightbulb Created with Sketch. 839
    Immutep events calendar has recently grown:-

    1. Cancer Progress by Cello Health - Virtual - May 4-6 -
    Of interest (see also NSCLC Summit July 13 - 15):-
    'Climbing the Highest Peak: Targeting PD-1/L1. Failures in Solid Tumors'.
    Note - panellist - Emmett Schmidt, MD, PhD, VP, Clinical Oncology, Lead, External Collaborations Oncology Early
    Development, Merck and Co..


    2. BIO International Convention - Bio Digital 2021. June 10 - 18
    Of interest - both these events advertise 'partnering opportunities' - we are on the extensive partner list. All big pharma represented too.

    3. Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit. July 13 -15.
    This one is not new (on the calendar) but check out who is on the 'expert speaker' list :-
    Emmett Schmidt, Merck and Tony Jarkowski Development Lead Bristol-Myers Squibb

    "Immutep will participate in the digital Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit.
    Frédéric Triebel, CSO & CMO of Immutep speaks on the subject:
    A Soluble LAG-3 Protein (Eftilagimod Alpha) with an Anti-PD-1 Antibody (Pembrolizumab):
    Results of a Phase II Study in NSCLC"

    I hope Fred and Marc have their dancing shoes on.....


 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
39.0¢
Change
-0.010(2.50%)
Mkt cap ! $566.5M
Open High Low Value Volume
39.0¢ 39.5¢ 38.5¢ $997.5K 2.559M

Buyers (Bids)

No. Vol. Price($)
4 85852 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 75389 4
View Market Depth
Last trade - 16.10pm 04/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.